Screening Strategies in Drug Discovery – News and Features
Industry Insight
Harnessing AI and Automation for the Future of Drug Discovery
In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.
Article
An Introduction to Protein Purification: Methods, Technologies and Applications
The ability to obtain pure proteins is essential for developing drugs, creating vaccines and understanding biological processes. In this article, we discuss what a typical protein purification protocol involves and the various techniques used.
Industry Insight
Semarion Wins SLAS Europe Ignite Award 2024
At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
Article
Mass Spectrometry Imaging in Pharmaceutical Development
In this article, we explore how mass spectrometry imaging technology is evolving into a high-resolution spatial biology toolset to transform drug discovery and development.
Industry Insight
SLAS Europe 2024 New Product Award Winners
Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.
News
Blood Clot-Targeting Drug Candidates Developed Through Computer-Aided Design
A team of researchers has created a new series of drug candidates against a hard-to-target receptor involved in the formation of blood clots.
Industry Insight
Expanding the Druggable Space With Degradation-Based Therapies
We spoke with Dr. Christian Dillon to learn more about degradation-based therapies, the challenges associated with their discovery and how innovative solutions are helping to realize the potential of this promising class of therapeutics.
News
Tiny RNA Targets May Provide New Treatment Options for Chronic Inflammation
UC Santa Cruz researchers have discovered a peptide in human RNA that regulates inflammation and may provide a new path for treating diseases such as arthritis and lupus.
News
First-of-its-Kind Cancer Drug Shows Anti-Tumor Activity in Animal Models
Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers have developed a first-of-its-kind drug that inhibits YB-1, effectively silencing those orders.
Article
qPCR vs dPCR: Choosing the Right PCR Technology To Suit Your Experimental Needs
How can you identify which technique is best suited to your research requirements? In this article, we explore the advantages of qPCR and dPCR, considering specific applications and deliverable metrics to help you choose the right technology to suit your experimental needs.
Advertisement